Elanco Competitors

Stocks Germany . 
Stock . Elanco Animal Health
5EA Stock  EUR 12.76  0.30  2.41%   
Elanco Animal Health competes with Superior Plus, Origin Agritech, Identiv, INTUITIVE SURGICAL, and Intel; as well as few others. The company classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. Analyzing Elanco Animal competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Elanco Animal to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Elanco Animal Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Elanco Animal competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
10.2612.7615.26
Details
Intrinsic
Valuation
LowRealHigh
10.0712.5715.07
Details
Naive
Forecast
LowNextHigh
9.0711.5714.08
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
12.3812.6312.88
Details

Elanco Animal Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Elanco Animal and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Elanco and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Elanco Animal Health does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
RS6
+ 0.92
IUI1
RS6
+ 0.91
INVN
IUI1
+ 0.89
INVN
VOW
+ 0.84
8SP
RS6
+ 0.84
INL
INL
+ 0.79
INVN
  
High negative correlations   
VOW
- 0.9
IUI1
RS6
- 0.89
VOW
IUI1
- 0.85
8SP
VOW
- 0.84
INVN
RS6
- 0.8
8SP
INVN
- 0.75
8SP

Risk-Adjusted Indicators

There is a big difference between Elanco Stock performing well and Elanco Animal Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Elanco Animal's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Elanco Animal Competitive Analysis

The better you understand Elanco Animal competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Elanco Animal's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Elanco Animal's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
5EA 8SP 39O1 INVN IUI1 INL VOW RS6 3RKU
 2.41 
 12.76 
Elanco
 2.65 
 4.40 
Superior
 4.96 
 2.54 
Origin
 6.27 
 3.74 
Identiv
 0.04 
 512.20 
INTUITIVE
 5.34 
 22.87 
Intel
 1.55 
 82.80 
Volkswagen
 0.23 
 305.20 
Reliance
 2.07 
 19.70 
RYOHIN
Market Volatility
(90 Days Market Risk)
Not too volatile
Relatively risky
Very risky
Moderately volatile
Very steady
Not too volatile
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Insignificant
OK
Good
Good
Very Weak
Good
Good
Odds of Financial Distress
(Probability Of Bankruptcy)
Quite High
Quite High
Low
Low
Low
Low
Low
Low
About Average
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Under Valued
Under Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Strong Sell
Strong Sell
Hold
Strong Hold
Cautious Hold
Strong Buy
Buy
Strong Hold
Current Ratio
1.64
1.33
N/A
1.31
N/A
N/A
N/A
4.06
4.01
Net Asset
16.48 B
4.48 B
135.96 M
96.66 M
12.97 B
182.1 B
528.61 B
10.33 B
N/A
Profit Margin
-0.0168
-0.0333
N/A
-0.0236
N/A
N/A
N/A
0.11
-1.73
EBITDA
703 M
202.9 M
N/A
4.1 M
1.94 B
21.3 B
49.43 B
2.73 B
38.5 B
Operating Margin
0.0883
0.0049
N/A
-0.0216
N/A
N/A
N/A
0.15
4.15
Current Valuation
10.92 B
2.78 B
78.28 M
149.13 M
86.49 B
126.75 B
201.15 B
12.83 B
(9.36 B)
Price To Book
0.89
1.76
4.72
2.37
8.3
1.18
0.53
1.78
0.02
Five Year Return
N/A
5.75
N/A
N/A
N/A
N/A
N/A
1.9
N/A
Beta
0.93
0.86
N/A
1.55
N/A
N/A
N/A
0.89
1.01
Number Of Employees
27
28
11
329
N/A
5
N/A
10
9.05 K
Shares Outstanding
474.2 M
200.7 M
N/A
22.51 M
N/A
N/A
N/A
58.79 M
263.03 M
Cash Flow From Operations
483 M
248.7 M
N/A
1.23 M
1.49 B
15.43 B
38.63 B
2.12 B
(3.52 B)
Annual Yield
N/A
0.0662
N/A
N/A
N/A
0.018
0.0401
0.0163
N/A
Total Debt
6.03 B
1.91 B
N/A
17.93 M
N/A
37.68 B
123.89 B
1.14 B
110.72 B
Return On Equity
-0.0104
-0.0634
N/A
-0.0353
N/A
N/A
N/A
0.28
N/A
Z Score
N/A
N/A
N/A
5.8
N/A
2.4
N/A
8.2
N/A
Return On Asset
0.0189
0.0026
N/A
-0.0151
N/A
N/A
N/A
0.16
N/A
Book Value Per Share
14.23
5.52
N/A
3.29
N/A
N/A
N/A
120.56
773.43
Total Asset
16.48 B
4.48 B
135.96 M
96.66 M
12.97 B
182.1 B
528.61 B
10.33 B
N/A
Debt To Equity
0.77
163.2
N/A
51.4
N/A
N/A
N/A
49.0
0.52
Target Price
34.71
N/A
N/A
21.25
N/A
N/A
N/A
181.17
N/A
Last Dividend Paid
N/A
0.72
N/A
N/A
N/A
0.33
4.8
3.5
0.19
Shares Owned By Institutions
99.73
36.16
N/A
67.68
N/A
N/A
N/A
83.58
0.16
Market Capitalization
5.6 B
1.54 B
42.71 M
145.66 M
109.12 B
182.18 B
117.75 B
13.85 B
4.38 B
Price To Earning
98.33
30.24
N/A
N/A
N/A
N/A
N/A
8.86
N/A
Price To Earnings To Growth
1.86
N/A
N/A
N/A
3.27
12.86
4.22
N/A
N/A
Price To Sales
1.19
0.46
5.11
1.36
16.13
1.7
0.35
0.65
0.01
Net Income
(74 M)
(112.5 M)
N/A
1.62 M
1.32 B
8.01 B
15.38 B
1.84 B
(6.93 B)
Earnings Per Share
-0.14
-0.4
N/A
-0.17
N/A
N/A
N/A
28.2
-0.2
Shares Owned By Insiders
0.27
0.35
N/A
4.27
N/A
N/A
N/A
0.86
N/A
Revenue
4.42 B
3.38 B
N/A
103.77 M
6.22 B
63.05 B
250.2 B
17.02 B
401.65 B
Cash And Equivalents
515 M
33.45 M
N/A
8.93 M
N/A
N/A
N/A
133.6 M
126.74 B
Cash Per Share
1.09
0.19
N/A
0.54
N/A
N/A
N/A
1.99
481.84
Gross Profit
2.5 B
1.15 B
N/A
37.07 M
N/A
N/A
N/A
5.26 B
190.92 B
Day Typical Price
12.76
4.4
2.53
3.74
512.2
22.87
82.8
305.2
19.7
Accumulation Distribution
N/A
N/A
0.0079
N/A
N/A
N/A
N/A
N/A
N/A
Market Facilitation Index
N/A
N/A
0.02
N/A
N/A
N/A
N/A
N/A
N/A
Daily Balance Of Power
9.2 T
(9,223,372,036,855)
6.0
(9,223,372,036,855)
9.2 T
(9,223,372,036,855)
(9,223,372,036,855)
9.2 T
9.2 T
Period Momentum Indicator
0.3
(0.12)
0.12
(0.25)
0.2
(1.29)
(1.30)
0.7
0.4
Rate Of Daily Change
1.02
0.97
1.05
0.94
1.0
0.95
0.98
1.0
1.02
Day Median Price
12.76
4.4
2.53
3.74
512.2
22.87
82.8
305.2
19.7
Price Action Indicator
0.15
(0.06)
0.07
(0.12)
0.1
(0.64)
(0.65)
0.35
0.2
Relative Strength Index
50.78
45.79
47.28
57.1
64.09
54.93
32.9
60.19
76.77
Coefficient Of Variation
(2,614)
(3,461)
2161.83
718.47
765.57
1212.3
(540.16)
752.04
787.97
Mean Deviation
1.71
2.07
3.58
2.09
1.24
2.54
1.25
1.32
1.51
Jensen Alpha
(0.23)
(0.08)
0.205
0.254
0.1853
0.1683
(0.31)
0.2538
0.2315
Total Risk Alpha
(0.44)
(0.56)
(0.43)
4.0E-4
(0.02)
(0.19)
(0.54)
(0.02)
(0.03)
Sortino Ratio
N/A
N/A
0.0274
0.1062
0.0906
0.0575
N/A
0.1012
0.0686
Downside Variance
N/A
N/A
15.28
6.69
1.63
7.92
N/A
2.69
4.08
Standard Deviation
2.5
3.35
4.77
2.79
1.75
3.34
1.66
2.1
1.98
Kurtosis
2.77
10.8
1.22
0.3239
6.28
0.1507
1.45
12.68
1.72
Potential Upside
4.07
3.36
8.41
5.59
3.28
7.04
2.08
2.94
3.25
Treynor Ratio
(0.09)
0.3494
4.05
0.3154
0.6715
0.2829
11.06
1.8
2.42
Maximum Drawdown
13.02
20.22
24.06
14.01
10.3
13.89
9.42
13.51
8.52
Variance
6.26
11.25
22.71
7.76
3.07
11.12
2.74
4.41
3.94
Market Risk Adjusted Performance
(0.08)
0.3594
4.06
0.3254
0.6815
0.2929
11.07
1.81
2.43
Risk Adjusted Performance
(0.02)
(0.01)
0.0437
0.1135
0.1053
0.0707
(0.14)
0.1078
0.103
Skewness
0.6348
(0.71)
0.8706
0.2605
1.79
0.4452
0.3337
2.32
0.3213
Semi Deviation
N/A
N/A
3.52
2.03
1.1
2.57
N/A
1.34
1.57
Information Ratio
(0.08)
(0.06)
0.0225
0.0985
0.066
0.0485
(0.25)
0.079
0.0698
Value At Risk
(4.32)
(4.74)
(5.47)
(4.04)
(1.96)
(4.28)
(2.99)
(2.17)
(3.01)
Expected Short fall
N/A
N/A
(4.94)
(2.52)
(1.42)
(3.16)
N/A
(1.55)
(1.97)
Downside Deviation
N/A
N/A
3.91
2.59
1.28
2.81
N/A
1.64
2.02
Semi Variance
N/A
N/A
12.38
4.13
1.2
6.6
N/A
1.79
2.46

Elanco Animal Competition Performance Charts

Five steps to successful analysis of Elanco Animal Competition

Elanco Animal's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Elanco Animal Health in relation to its competition. Elanco Animal's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Elanco Animal in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Elanco Animal's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Elanco Animal Health, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Elanco Animal position

In addition to having Elanco Animal in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Momentum Thematic Idea Now

Momentum
Momentum Theme
Large corporations operating in software, education, financial and car manufacturing industries. The Momentum theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Momentum Theme or any other thematic opportunities.
View All  Next Launch

Additional Information and Resources on Investing in Elanco Stock

When determining whether Elanco Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Elanco Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Elanco Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Elanco Animal Health Stock:
How To Invest In Elanco
Details
Is Elanco Stock a good investment?
Details
What is Elanco Animal's Net Worth?
Details
Largest Pharmaceuticals Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out Elanco Animal Correlation with its peers.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
Altman
Z Score
Details
Intrinsic
Valuation
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Elanco Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elanco Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elanco Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY